Publication | Closed Access

Luteolin improves non-alcoholic fatty liver disease in db/db mice by inhibition of liver X receptor activation to down-regulate expression of sterol regulatory element binding protein 1c

Metabolic SyndromeHepatologyBiochemistrySterol Regulatory ElementLiver PhysiologyMedicinePathologyProtein 1CLiver DiseaseFatty Liver DiseasePharmacologyDb/db MiceLipid SynthesisHealth Sciences